Neogen (NEOG) EBT Growth (1y) (2011 - 2026)
Neogen (NEOG) EBT Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -18.50% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 11.26% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 45.44% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 44.35% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 5.78% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 74.66% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 103.34% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -27.02% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Neogen | 2.09 Bn | 1.93 Bn | 99.00 Mn | -109.28% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -109.28% |
| Nov 30, 2025 | 95.73% |
| Aug 31, 2025 | 380.66% |
| May 31, 2025 | -9,764.20% |
| Feb 28, 2025 | -66.61% |
| Nov 30, 2024 | -12,618.76% |
| Aug 31, 2024 | -1,038.60% |
| May 31, 2024 | -183.65% |
| Feb 29, 2024 | -157.61% |
| Nov 30, 2023 | 89.01% |
| Aug 31, 2023 | -75.03% |
| May 31, 2023 | -59.54% |
| Feb 28, 2023 | -134.02% |
| Nov 30, 2022 | -363.70% |
| Aug 31, 2022 | -69.35% |
| May 31, 2022 | -6.14% |
| Feb 28, 2022 | -58.42% |
| Nov 30, 2021 | -33.14% |
| Aug 31, 2021 | 9.68% |
| May 31, 2021 | -4.87% |